The association between antidepressant dosage titration and medication adherence among patients with depression

Chung Hsuen Wu, Joel F. Farley, Bradley N. Gaynes

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background To evaluate the association between upward dose titration of antidepressants and medication adherence during the first 6 months of a newly initiated antidepressant treatment for patients with major depressive disorder (MDD). Methods We conducted a retrospective observational cohort study using Thomson Reuters MarketScan Commercial Claims and Encounters Claims data. We identified 40,873 patients aged 18-64 with MDD newly initiating a selective serotonin reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor, or bupropion between July 1, 2005 and June 30, 2007. Patients with titration (defined as antidepressant initiation at doses equal or lesser than American Psychiatric Association treatment guidelines with a dosage increase in the first 60 days of treatment) were compared to patients with no titration. Adherence was measured as the proportion of days covered (PDC) on antidepressant treatment. Patients with PDC ≥ 80% were considered adherent. Persistence was measured as the duration of time from initiation to a 30-day gap in antidepressant treatment. Multivariate logistic regression and Cox-proportional hazard models examined the influence of titration on adherence and persistence, respectively. Results Adherence was greater in the titration group than in the nontitration group (67.5% versus 45.2%, P

Original languageEnglish
Pages (from-to)506-514
Number of pages9
JournalDepression and Anxiety
Volume29
Issue number6
DOIs
Publication statusPublished - Jun 2012
Externally publishedYes

Fingerprint

Medication Adherence
Antidepressive Agents
Depression
Major Depressive Disorder
Therapeutics
Bupropion
Serotonin Uptake Inhibitors
Proportional Hazards Models
Observational Studies
Cohort Studies
Logistic Models
Guidelines

Keywords

  • adherence
  • anxiety
  • depression
  • dose titration
  • major depressive disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

The association between antidepressant dosage titration and medication adherence among patients with depression. / Wu, Chung Hsuen; Farley, Joel F.; Gaynes, Bradley N.

In: Depression and Anxiety, Vol. 29, No. 6, 06.2012, p. 506-514.

Research output: Contribution to journalArticle

@article{48ebc146a0d446e59f779049eb3d149f,
title = "The association between antidepressant dosage titration and medication adherence among patients with depression",
abstract = "Background To evaluate the association between upward dose titration of antidepressants and medication adherence during the first 6 months of a newly initiated antidepressant treatment for patients with major depressive disorder (MDD). Methods We conducted a retrospective observational cohort study using Thomson Reuters MarketScan Commercial Claims and Encounters Claims data. We identified 40,873 patients aged 18-64 with MDD newly initiating a selective serotonin reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor, or bupropion between July 1, 2005 and June 30, 2007. Patients with titration (defined as antidepressant initiation at doses equal or lesser than American Psychiatric Association treatment guidelines with a dosage increase in the first 60 days of treatment) were compared to patients with no titration. Adherence was measured as the proportion of days covered (PDC) on antidepressant treatment. Patients with PDC ≥ 80{\%} were considered adherent. Persistence was measured as the duration of time from initiation to a 30-day gap in antidepressant treatment. Multivariate logistic regression and Cox-proportional hazard models examined the influence of titration on adherence and persistence, respectively. Results Adherence was greater in the titration group than in the nontitration group (67.5{\%} versus 45.2{\%}, P",
keywords = "adherence, anxiety, depression, dose titration, major depressive disorder",
author = "Wu, {Chung Hsuen} and Farley, {Joel F.} and Gaynes, {Bradley N.}",
year = "2012",
month = "6",
doi = "10.1002/da.21952",
language = "English",
volume = "29",
pages = "506--514",
journal = "Depression and Anxiety",
issn = "1091-4269",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - The association between antidepressant dosage titration and medication adherence among patients with depression

AU - Wu, Chung Hsuen

AU - Farley, Joel F.

AU - Gaynes, Bradley N.

PY - 2012/6

Y1 - 2012/6

N2 - Background To evaluate the association between upward dose titration of antidepressants and medication adherence during the first 6 months of a newly initiated antidepressant treatment for patients with major depressive disorder (MDD). Methods We conducted a retrospective observational cohort study using Thomson Reuters MarketScan Commercial Claims and Encounters Claims data. We identified 40,873 patients aged 18-64 with MDD newly initiating a selective serotonin reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor, or bupropion between July 1, 2005 and June 30, 2007. Patients with titration (defined as antidepressant initiation at doses equal or lesser than American Psychiatric Association treatment guidelines with a dosage increase in the first 60 days of treatment) were compared to patients with no titration. Adherence was measured as the proportion of days covered (PDC) on antidepressant treatment. Patients with PDC ≥ 80% were considered adherent. Persistence was measured as the duration of time from initiation to a 30-day gap in antidepressant treatment. Multivariate logistic regression and Cox-proportional hazard models examined the influence of titration on adherence and persistence, respectively. Results Adherence was greater in the titration group than in the nontitration group (67.5% versus 45.2%, P

AB - Background To evaluate the association between upward dose titration of antidepressants and medication adherence during the first 6 months of a newly initiated antidepressant treatment for patients with major depressive disorder (MDD). Methods We conducted a retrospective observational cohort study using Thomson Reuters MarketScan Commercial Claims and Encounters Claims data. We identified 40,873 patients aged 18-64 with MDD newly initiating a selective serotonin reuptake inhibitor, serotonin-norepinephrine reuptake inhibitor, or bupropion between July 1, 2005 and June 30, 2007. Patients with titration (defined as antidepressant initiation at doses equal or lesser than American Psychiatric Association treatment guidelines with a dosage increase in the first 60 days of treatment) were compared to patients with no titration. Adherence was measured as the proportion of days covered (PDC) on antidepressant treatment. Patients with PDC ≥ 80% were considered adherent. Persistence was measured as the duration of time from initiation to a 30-day gap in antidepressant treatment. Multivariate logistic regression and Cox-proportional hazard models examined the influence of titration on adherence and persistence, respectively. Results Adherence was greater in the titration group than in the nontitration group (67.5% versus 45.2%, P

KW - adherence

KW - anxiety

KW - depression

KW - dose titration

KW - major depressive disorder

UR - http://www.scopus.com/inward/record.url?scp=84862752878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862752878&partnerID=8YFLogxK

U2 - 10.1002/da.21952

DO - 10.1002/da.21952

M3 - Article

C2 - 22553149

AN - SCOPUS:84862752878

VL - 29

SP - 506

EP - 514

JO - Depression and Anxiety

JF - Depression and Anxiety

SN - 1091-4269

IS - 6

ER -